2025 HCPCS Code J9359
Injection, loncastuximab tesirine-lpyl, 0.075 mg
TAGS: loncastuximab| Short Description | Inj lon tesirin-lpyl 0.075mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | April 01, 2022 |
| HCPCS Action Effective Date | April 01, 2022 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J2271 - Morphine so4 injection 100mg
- J2272 - Inj, morphine (fresenius)
- J2274 - Inj morphine pf epid ithc
- J2275 - Morphine sulfate injection
- J2277 - Inj, motixafortide, 0.25 mg
- J2278 - Ziconotide injection
- J2280 - Inj, moxifloxacin 100 mg
- J2281 - Inj moxifloxacin (fres kabi)
- J2300 - Inj nalbuphine hydrochloride
- J2305 - Inj, nitroglycerin, 5 mg
- J2310 - Inj naloxone hydrochloride
- J2311 - Inj, naloxone hcl (zimhi)
- J2315 - Naltrexone, depot form
- J2320 - Nandrolone decanoate 50 mg
- J2323 - Natalizumab injection
- J2325 - Nesiritide injection
- J2326 - Inj, nusinersen, 0.1mg
- J2327 - Inj risankizumab-rzaa 1 mg
- J2329 - Inj ublituximab-xiiy, 1 mg
- J2350 - Injection, ocrelizumab, 1 mg